"they could get market exclusivity for a new indication and even longer if they are able to obtain a patent on the new indication. However, the drug company would generally need a new dosing strength or formulation to make this commercially reasonable since doctors could, and would, write prescriptions for the old version for the new indication (assuming the drugs are the same."
News 
Market Data 
Discover 
